Prevalence of Anemia and Its Associated Factors in Antiretroviral-Treated HIV/AIDS-Positive Adults from 2013 to 2018 at Debre Berhan Referral Hospital, Ethiopia.

Q3 Medicine
Advances in Hematology Pub Date : 2020-03-11 eCollection Date: 2020-01-01 DOI:10.1155/2020/2513578
Yared Asmare Aynalem, Wondimeneh Shibabaw Shiferaw, Zeleke Woldiye
{"title":"Prevalence of Anemia and Its Associated Factors in Antiretroviral-Treated HIV/AIDS-Positive Adults from 2013 to 2018 at Debre Berhan Referral Hospital, Ethiopia.","authors":"Yared Asmare Aynalem,&nbsp;Wondimeneh Shibabaw Shiferaw,&nbsp;Zeleke Woldiye","doi":"10.1155/2020/2513578","DOIUrl":null,"url":null,"abstract":"<p><p><i>Introduction</i>. Anemia was defined as a hemoglobin level of less than or equal to 13.9 g/dl for male and less than or equal to 12.2 g/dl for female adults. It is one of the most common hematological abnormalities in people living with human immunodeficiency virus/acquired immunodeficiency syndrome (HIV/AIDS) and is a determining factor for disease progression and death. Among the countries in sub-Saharan Africa, Ethiopia is one of the most affected nations by HIV. Therefore, this study aimed to assess the prevalence of anemia and its associated factors among HIV-positive adults that had received antiretroviral treatment (ART) at Debre Berhan Referral Hospital.</p><p><strong>Methods: </strong>An institution-based, descriptive, cross-sectional study was conducted involving 263 adults with HIV/AIDS that had undergone ART at Debre Berhan Referral Hospital, Ethiopia. Data were collected from patient charts using systematic sampling with a pretested data extraction tool and entered using EpiData 3.1. Variables having a <i>p</i> value ≤0.25 in the bivariate were fitted to a multivariable regression model with a 95% confidence interval. <i>p</i> value ≤0.25 in the bivariate were fitted to a multivariable regression model with a 95% confidence interval.</p><p><strong>Results: </strong>Among the 263 HIV-positive patients, 237 (90.11%) were included in the final analysis. The overall prevalence of anemia was 26.2%. Factors that were significantly associated with anemia were past opportunistic infections, patients being in WHO clinical stage III and IV, and a BMI <18.5. Conversely, those patients who took anti-TB medication were less likely to have anemia.</p><p><strong>Conclusion: </strong>Our study shows that the severity of anemia among HIV/AIDS patients that had undergone ART is lower than most studies conducted in Ethiopia. We also found that opportunistic infection, WHO clinical staging, anti-TB treatment, and low BMI were significantly associated with anemia. Therefore, routine screening of patient nutritional status and opportunistic infections may be useful in predicting and controlling anemia in HIV/AIDS patients.</p>","PeriodicalId":7325,"journal":{"name":"Advances in Hematology","volume":"2020 ","pages":"2513578"},"PeriodicalIF":0.0000,"publicationDate":"2020-03-11","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1155/2020/2513578","citationCount":"11","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Advances in Hematology","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1155/2020/2513578","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2020/1/1 0:00:00","PubModel":"eCollection","JCR":"Q3","JCRName":"Medicine","Score":null,"Total":0}
引用次数: 11

Abstract

Introduction. Anemia was defined as a hemoglobin level of less than or equal to 13.9 g/dl for male and less than or equal to 12.2 g/dl for female adults. It is one of the most common hematological abnormalities in people living with human immunodeficiency virus/acquired immunodeficiency syndrome (HIV/AIDS) and is a determining factor for disease progression and death. Among the countries in sub-Saharan Africa, Ethiopia is one of the most affected nations by HIV. Therefore, this study aimed to assess the prevalence of anemia and its associated factors among HIV-positive adults that had received antiretroviral treatment (ART) at Debre Berhan Referral Hospital.

Methods: An institution-based, descriptive, cross-sectional study was conducted involving 263 adults with HIV/AIDS that had undergone ART at Debre Berhan Referral Hospital, Ethiopia. Data were collected from patient charts using systematic sampling with a pretested data extraction tool and entered using EpiData 3.1. Variables having a p value ≤0.25 in the bivariate were fitted to a multivariable regression model with a 95% confidence interval. p value ≤0.25 in the bivariate were fitted to a multivariable regression model with a 95% confidence interval.

Results: Among the 263 HIV-positive patients, 237 (90.11%) were included in the final analysis. The overall prevalence of anemia was 26.2%. Factors that were significantly associated with anemia were past opportunistic infections, patients being in WHO clinical stage III and IV, and a BMI <18.5. Conversely, those patients who took anti-TB medication were less likely to have anemia.

Conclusion: Our study shows that the severity of anemia among HIV/AIDS patients that had undergone ART is lower than most studies conducted in Ethiopia. We also found that opportunistic infection, WHO clinical staging, anti-TB treatment, and low BMI were significantly associated with anemia. Therefore, routine screening of patient nutritional status and opportunistic infections may be useful in predicting and controlling anemia in HIV/AIDS patients.

Abstract Image

2013 - 2018年埃塞俄比亚Debre Berhan转诊医院接受抗逆转录病毒治疗的艾滋病毒/艾滋病阳性成年人贫血患病率及其相关因素
介绍。贫血被定义为男性血红蛋白水平低于或等于13.9 g/dl,女性成人血红蛋白水平低于或等于12.2 g/dl。它是人类免疫缺陷病毒/获得性免疫缺陷综合征(艾滋病毒/艾滋病)患者中最常见的血液学异常之一,是疾病进展和死亡的决定性因素。在撒哈拉以南的非洲国家中,埃塞俄比亚是受艾滋病影响最严重的国家之一。因此,本研究旨在评估在Debre Berhan转诊医院接受抗逆转录病毒治疗(ART)的hiv阳性成人中贫血的患病率及其相关因素。方法:对263名在埃塞俄比亚Debre Berhan转诊医院接受抗逆转录病毒治疗的成人艾滋病毒/艾滋病患者进行了一项以机构为基础的描述性横断面研究。采用预先测试的数据提取工具进行系统抽样,从患者病历中收集数据,并使用EpiData 3.1输入数据。双变量中p值≤0.25的变量拟合到多变量回归模型中,置信区间为95%。双变量P值≤0.25拟合为多变量回归模型,置信区间为95%。结果:263例hiv阳性患者中,最终纳入237例(90.11%)。贫血的总患病率为26.2%。与贫血显著相关的因素是过去的机会性感染,患者处于世卫组织临床III期和IV期,以及BMI。结论:我们的研究表明,接受抗逆转录病毒治疗的艾滋病毒/艾滋病患者的贫血严重程度低于在埃塞俄比亚进行的大多数研究。我们还发现机会性感染、WHO临床分期、抗结核治疗和低BMI与贫血显著相关。因此,常规筛查患者的营养状况和机会性感染可能有助于预测和控制HIV/AIDS患者的贫血。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
Advances in Hematology
Advances in Hematology Medicine-Hematology
CiteScore
3.30
自引率
0.00%
发文量
10
审稿时长
15 weeks
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信